# Renal Blood Flow Measurement With Positron Emission Tomography (PET)

> **NCT00714142** · PHASE2 · COMPLETED · sponsor: **Jeffrey L. Lacy** · enrollment: 30 (actual)

## Conditions studied

- Renal Failure
- Renal Artery Stenosis

## Interventions

- **DRUG:** 62Cu-ethylglyoxal bis(thiosemicarbazone)
- **DRUG:** 15O-water
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT00714142
- **Lead sponsor:** Jeffrey L. Lacy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00714142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00714142, "Renal Blood Flow Measurement With Positron Emission Tomography (PET)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00714142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*